Van Andel Research Institute To Run In-House Protein Arrays on Aushon BioSystems' 2470 Platform

Adoption of the platform will facilitate use of novel protein microarray formats developed at VARI as part of its research into blood tests to allow earlier detection and more accurate diagnosis of cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.